Author:
Yee-de León Juan F.,Soto-García Brenda,Aráiz-Hernández Diana,Delgado-Balderas Jesús Rolando,Esparza Miguel,Aguilar-Avelar Carlos,Wong-Campos J. D.,Chacón Franco,López-Hernández José Y.,González-Treviño A. Mauricio,Yee-de León José R.,Zamora-Mendoza Jorge L.,Alvarez Mario M.,Trujillo-de Santiago Grissel,Gómez-Guerra Lauro S.,Sánchez-Domínguez Celia N.,Velarde-Calvillo Liza P.,Abarca-Blanco Alejandro
Abstract
AbstractThe detection and analysis of circulating tumor cells (CTCs) may enable a broad range of cancer-related applications, including the identification of acquired drug resistance during treatments. However, the non-scalable fabrication, prolonged sample processing times, and the lack of automation, associated with most of the technologies developed to isolate these rare cells, have impeded their transition into the clinical practice. This work describes a novel membrane-based microfiltration device comprised of a fully automated sample processing unit and a machine-vision-enabled imaging system that allows the efficient isolation and rapid analysis of CTCs from blood. The device performance was characterized using four prostate cancer cell lines, including PC-3, VCaP, DU-145, and LNCaP, obtaining high assay reproducibility and capture efficiencies greater than 93% after processing 7.5 mL blood samples spiked with 100 cancer cells. Cancer cells remained viable after filtration due to the minimal shear stress exerted over cells during the procedure, while the identification of cancer cells by immunostaining was not affected by the number of non-specific events captured on the membrane. We were also able to identify the androgen receptor (AR) point mutation T878A from 7.5 mL blood samples spiked with 50 LNCaP cells using RT-PCR and Sanger sequencing. Finally, CTCs were detected in 8 out of 8 samples from patients diagnosed with metastatic prostate cancer (mean ± SEM = 21 ± 2.957 CTCs/mL, median = 21 CTCs/mL), demonstrating the potential clinical utility of this device.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Reviews Cancer 3, 453–458 (2003).
2. Dotan, E., Cohen, S. J., Alpaugh, K. R. & Meropol, N. J. Circulating tumor cells: Evolving evidence and future challenges. The Oncologist 14, 1070–1082 (2009).
3. Pantel, K. & Speicher, M. The biology of circulating tumor cells. Oncogene 35, 1216–1224 (2016).
4. Ashworth, T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. The Medical Journal of Australia 14, 146–147 (1869).
5. Yu, M., Stott, S., Toner, M., Maheswaran, S. & Haber, D. A. Circulating tumor cells: approaches to isolation and characterization. The Journal of Cell Biology 192, 373–382 (2011).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献